Detection of KIT mutations in core binding factor acute myeloid leukemia

Autor: Dalia Negm Eldin, Nayera Hamdy, Bahia Y. Riad, Passant Badr, Ghada M. Elsayed
Rok vydání: 2018
Předmět:
0301 basic medicine
medicine.medical_specialty
FLT-3-ITD
FLT3 internal tandem duplication

lcsh:RC254-282
Gastroenterology
Article
03 medical and health sciences
CBF-AML
0302 clinical medicine
hemic and lymphatic diseases
Internal medicine
medicine
Leukocytosis
NCCN
National comprehensive cancer network

Core binding factor acute myeloid leukemia
ELN
European Leukemia Network

FLT-3 mutations
business.industry
Significant difference
Hematology
KIT mutations
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
PCR-RFLP
Polymerase chain reaction restriction fragment length polymorphism

HRM
High resolution melting curve analysis

030104 developmental biology
Oncology
030220 oncology & carcinogenesis
cardiovascular system
medicine.symptom
business
HRM analysis
CBF-AML
core binding factor AML

circulatory and respiratory physiology
Zdroj: Leukemia Research Reports
Leukemia Research Reports, Vol 10, Iss, Pp 20-25 (2018)
ISSN: 2213-0489
DOI: 10.1016/j.lrr.2018.06.004
Popis: We have investigated the frequency and the effect of KIT mutations on the outcome of patients with CBF-AML. 69 patients (34 pediatrics and 35 adults) with CBF-AML were enrolled in the study. The frequency of KIT mutations was higher in adults compared to pediatrics (22.9% and 14.7%, p = 0.38) respectively. Leukocytosis ≥ 20 × 109 /L was significantly associated with pediatrics compared to adults. t(8;21)(q22;22) was significantly associated with thrombocytopenia in adults. We conclude that no significant difference is found between KIT mutated and unmutated CBF-AML in adults and pediatrics. Children with CBF-AML present with leukocytosis. t(8;21) is associated with thrombocytopenia. Keywords: CBF-AML, KIT mutations, FLT-3 mutations, HRM analysis
Databáze: OpenAIRE